DPA International on MSN6d
German science and tech giant Merck confirms full-year guidanceGerman science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...
Boston has become world-famous for its booming biotech industry. Over the past 20 years, the city has been buzzing with ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Explaining what first spurred his philanthropy, US billionaire Michael Novogratz uses Wall Street terminology. “There’s kind ...
The Canadian Press on MSN4d
Today-History-Oct27Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...
Merck also changed the outlook for its Healthcare business to "slight growth", compared to a previously expected ...
Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...
The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback